Ambrx Biopharma Inc. Debt to Equity Ratio 2023-2023 | AMAM
Current and historical debt to equity ratio values for Ambrx Biopharma Inc. (AMAM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Ambrx Biopharma Inc. debt/equity for the three months ending June 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-06-30 | $0.03B | $0.25B | 0.12 |
| 2023-03-31 | $0.03B | $0.18B | 0.15 |
| 2022-12-31 | $0.03B | $0.12B | 0.25 |
| 2022-06-30 | $0.04B | $0.14B | 0.28 |
| 2022-03-31 | $0.00B | 0.00 | |
